主页文献库搜索
Massive Parallel Sequencing for Diagnostic Genetic Testing of BRCA Genes--a S...

Ermolenko(Natalya A),Boyarskikh(Uljana A),... Asian Pac J Cancer Prev 2016-09-26

...BRCA2 genes on an Illumina MiSeq to identify disease-causing mutations in patients with hereditary breast or ovarian can...

Targeting the DNA Damage Response in Cancer.

O'Connor(Mark J) Mol Cell 2016-03-09

...BRCA2 mutations, represents the first medicine based on this principle, exploiting an underlying cause of tumor formatio...

Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the ev...

van den Broek(Alexandra J),Schmidt(Marjank... PLoS One 2016-03-15

...BRCA2 there was a tendency towards a worse breast cancer-specific and overall survival, however, results were heterogene...

Functional variant analyses (FVAs) predict pathogenicity in the BRCA1 DNA dou...

Loke(Johnny),Pearlman(Alexander),Upadhyay(... Hum Mol Genet 2016-02-16

Heritable mutations in the BRCA1 and BRCA2 and other genes in the DNA double-strand break (DSB) repair pathway disrupt b...

The importance of proper bioinformatics analysis and clinical interpretation ...

Varga(Elizabeth),Chao(Elizabeth C),Yeager(... Fam Cancer 2016-06-10

...BRCA2 "R645fs*15″ and MLH1 "E694*". Because constitutional BRCA2 and MLH1 gene mutations are associated with Hereditary ...

PARP inhibitors: A new era of targeted therapy.

Tangutoori(Shifalika),Baldwin(Paige),Sridh... Maturitas 2016-03-31

...BRCA2 mutations. Currently, clinical trials with several PARP inhibitors are being conducted to assess the toxicities, t...

Analysis of PALB2 in a cohort of Italian breast cancer patients: identificati...

Vietri(Maria Teresa),Caliendo(Gemma),Schia... Fam Cancer 2016-06-10

...BRCA2 (BRCAX). Genomic DNA was isolated from peripheral blood lymphocytes, PALB2 coding regions and adjacent intronic we...

Large genomic rearrangements in the familial breast and ovarian cancer gene B...

James(Paul A),Sawyer(Sarah),Boyle(Samantha... Fam Cancer 2016-03-08

Large genomic rearrangements (LGRs) account for at least 10% of the mutations in BRCA1 and 5% of BRCA2 mutations in outb...

RNA Interference Using c-Myc-Conjugated Nanoparticles Suppresses Breast and C...

Tangudu(Naveen K),Verma(Vinod K),Clemons(T... Mol Cancer Ther 2016-02-01

...Brca2/p53-mutant mammary tumors following daily intratumoral treatment with nanoparticles conjugated to c-Myc shRNA. Sec...

Two novel frameshift mutations in BRCA2 gene detected by next generation sequ...

Hernan(I),Mañé(B),Borràs(E),de Sousa Dias(... Clin Transl Oncol 2016-04-06

To analyze BRCA1 and BRCA2 genes using a cost-effective and rapid approach based on next generation sequencing (NGS) tec...

上一页 83 84 85 86 87 88 89 90 91 下一页 87 / 共 632

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com